Artera Launches with $90 Million in Funding to Personalize Cancer Therapy With Multimodal AI
Patient capital. Lasting connections. Strategic direction.
We back the bold and the daring—pioneers.
Conquering, holding, venturing.
Join us at the edge.
Of scientific discovery and engineering innovation.
Walden Catalyst fuses a team of innovators and entrepreneurs.
Passionate about disruption, committed to excellence.
Partners to the bold and brave.
Positive in human impact.
Powering the future of technology.
Catalysts of success for over 30 years.
The latest news from us
and our portfolio companies
Artera Launches with $90 Million in Funding to Personalize Cancer Therapy With Multimodal AI
Founder Spotlight: As a next-generation Web3 infrastructure company, Ingonyama is building an optimized hardware/software stack for ZK proofs and other advanced cryptographic primitives. Dive into ZK protocol with Omer Shlomovits, Founder of Ingonyama.
Was 2022 a pivotal year for European Deep Tech? Read our European Deep Tech Report in collaboration with Dealroom and Lakestar to learn more about it.